Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body

• Status: Terminated
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to estimate the effects of multiple doses of cimetidine on the pharmacokinetics of a single dose of PD 0332334 and to evaluate the safety and tolerability of PD 0332334 when co-administered with cimetidine.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Pfizer
• Treatments: Cimetidine

Criteria

Inclusion Criteria:

• healthy

• male or female adults

Exclusion Criteria:

• Current or history of clinically significant medical illness

• Smokers

• Illicit drug use